# Amryt Pharma plc (AMYT)

Source: https://www.quantisnow.com/company/AMYT
Generated: 2026-11-11T06:11:22.080Z

- Ticker: AMYT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: amrytpharma.com

## About

Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy. It also develops FILSUVEZ drug candidate, which is in Phase 3 EASE trial for the treatment of severe epidermolysis bullosa (EB), a rare and genetic skin disease; and AP103 that is in preclinical stage for the treatment of patients with recessive dystrophic EB, a subset of EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.

## Latest AMYT news and filings

- 2023-04-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-amryt-pharma-plc-4370106)
- 2023-04-24 10:00 UTC [SEC Form 15F-12B filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-15f-12b-filed-by-amryt-pharma-plc-4370103)
- 2023-04-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-amryt-pharma-plc-4370098)
- 2023-04-24 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-effect-filed-by-amryt-pharma-plc-4370097)
- 2023-04-18 21:03 UTC [SEC Form POS AM filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-amryt-pharma-plc-4351624)
- 2023-04-18 21:01 UTC [SEC Form POS AM filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-amryt-pharma-plc-4351591)
- 2023-04-18 21:00 UTC [SEC Form POS AM filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-amryt-pharma-plc-4351569)
- 2023-04-18 20:15 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Amryt Pharma plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-amryt-pharma-plc-amendment-4350949)
- 2023-04-12 21:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-amryt-pharma-plc-4328830)
- 2023-04-12 12:20 UTC [SEC Form 25-NSE filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-amryt-pharma-plc-4325118)
- 2023-04-12 11:58 UTC [Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc](https://www.quantisnow.com/insight/chiesi-farmaceutici-spa-completes-acquisition-of-amryt-pharma-plc-4324795)
- 2023-04-12 11:00 UTC [Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc](https://www.quantisnow.com/insight/chiesi-farmaceutici-spa-completes-acquisition-of-amryt-pharma-plc-4324485)
- 2023-04-03 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-amryt-pharma-plc-4286251)
- 2023-04-03 11:00 UTC [High Court of Justice of England and Wales Sanctions Scheme of Arrangement](https://www.quantisnow.com/insight/high-court-of-justice-of-england-and-wales-sanctions-scheme-4284916)
- 2023-03-23 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-amryt-pharma-plc-4239585)
- 2023-03-22 15:01 UTC [Market Chatter] [Amryt Pharma Shareholders Approve Acquisition Of Amryt Pharma By Chiesi Farmaceutici; Terms Not Disclosed](https://www.quantisnow.com/insight/amryt-pharma-shareholders-approve-acquisition-of-amryt-pharma-by-chiesi-4234777)
- 2023-03-22 15:00 UTC [Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici](https://www.quantisnow.com/insight/amryt-pharma-shareholders-approve-acquisition-of-amryt-pharma-by-chiesi-4234724)
- 2023-03-14 12:45 UTC [Market Insight] [Top 5 Health Care Stocks That Are Ticking Portfolio Bombs](https://www.quantisnow.com/insight/top-5-health-care-stocks-that-are-ticking-portfolio-bombs-4197247)
- 2023-02-16 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-amryt-pharma-plc-4074782)
- 2023-02-16 12:00 UTC [AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023](https://www.quantisnow.com/insight/amryt-publishes-scheme-circular-and-announces-the-shareholder-meetings-to-4074655)
- 2023-02-13 15:24 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Amryt Pharma plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-amryt-pharma-plc-amendment-4046854)
- 2023-02-10 21:00 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Amryt Pharma plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-amryt-pharma-plc-amendment-4041264)
- 2023-02-10 14:48 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Amryt Pharma plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-amryt-pharma-plc-amendment-4038162)
- 2023-01-18 15:00 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-january-18-2023-3922993)
- 2023-01-18 11:12 UTC [Market Insight] [HC Wainwright & Co. Downgrades Amryt Pharma to Neutral](https://www.quantisnow.com/insight/hc-wainwright-co-downgrades-amryt-pharma-to-neutral-3921005)
- 2023-01-10 15:01 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-january-10-2023-3894855)
- 2023-01-10 14:23 UTC [Market Insight] [Maxim Group Downgrades Amryt Pharma to Hold](https://www.quantisnow.com/insight/maxim-group-downgrades-amryt-pharma-to-hold-3894523)
- 2023-01-10 12:48 UTC [Market Insight] [Cantor Fitzgerald Downgrades Amryt Pharma to Neutral, Lowers Price Target to $14.75](https://www.quantisnow.com/insight/cantor-fitzgerald-downgrades-amryt-pharma-to-neutral-lowers-price-target-3893093)
- 2023-01-10 12:45 UTC [Market Insight] [Canaccord Genuity Downgrades Amryt Pharma to Hold, Lowers Price Target to $17](https://www.quantisnow.com/insight/canaccord-genuity-downgrades-amryt-pharma-to-hold-lowers-price-target-3893075)
- 2023-01-09 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Amryt Pharma plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-amryt-pharma-plc-3890608)
- 2023-01-09 19:27 UTC [Market Insight] [S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher](https://www.quantisnow.com/insight/sp-500-gains-06-albireo-pharma-shares-spike-higher-3890046)
- 2023-01-09 18:42 UTC [Market Insight] [Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-cutera-shares-are-trading-lower-by-23-here-are-3889865)
- 2023-01-09 17:30 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-3889548)
- 2023-01-09 17:07 UTC [Market Insight] [Nasdaq Surges Over 200 Points; Crude Oil Rises 2%](https://www.quantisnow.com/insight/nasdaq-surges-over-200-points-crude-oil-rises-2-3889426)
- 2023-01-09 15:36 UTC [Market Insight] [Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday](https://www.quantisnow.com/insight/tesla-zillow-albireo-pharma-and-some-other-big-stocks-moving-3888908)
- 2023-01-09 15:01 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-january-9-2023-3888685)
- 2023-01-09 14:59 UTC [Market Insight] [US Stocks Open Higher; Dow Rises 150 Points](https://www.quantisnow.com/insight/us-stocks-open-higher-dow-rises-150-points-3888598)
- 2023-01-09 13:51 UTC [Market Chatter] [Amryt Pharma shares are trading higher after Chiesi Farmaceutici announced it will acquire the company for $14.50 per ADS plus contingent value rights of up to an additional $2.50 per ADS.](https://www.quantisnow.com/insight/amryt-pharma-shares-are-trading-higher-after-chiesi-farmaceutici-announced-3887974)
- 2023-01-09 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-3887541)
- 2023-01-09 13:04 UTC [Market Insight] [Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-cincor-pharma-shares-are-trading-higher-by-140-here-3887518)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AMYT
- Earnings history: https://www.quantisnow.com/earnings/AMYT
- Dividend history: https://www.quantisnow.com/dividends/AMYT
- Insider transactions: https://www.quantisnow.com/insiders/AMYT
- Options chain: https://www.quantisnow.com/options/AMYT
- SEC 8-K filings only: https://www.quantisnow.com/company/AMYT/8-k
- RSS and alerts for AMYT: https://www.quantisnow.com/docs/rss-feeds.md